Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $209.95 | Total: $1,049.75 |
| 1 | 10 | $177.84 | Total: $1,778.40 |
| 1 | 25 | $150.67 | Total: $3,766.75 |
| 1 | 50 | $128.44 | Total: $6,422.00 |
| 1 | 100 | $111.15 | Total: $11,115.00 |
Overview
Rafabegron (TAK677) is a potent and selective ?3 adrenergic receptor agonist for the study of diabetes and obesity.
Chemical Properties
| Molecular Formula | C21H23ClN2O4 |
| Molecular Weight | 402.87 |
| CAS Numbers | 244081-42-3 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | O(CC(O)=O)C1=C2C(C(C[C@H](NC[C@H](O)C3=CC(Cl)=CC=C3)C)=CN2)=CC=C1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Thiagamoorthy G, Giarenis I, Cardozo L. Early investigational ?3 adreno-receptor agonists for the management of the overactive bladder syndrome. Expert Opin Investig Drugs. 2015;24[10] 1299-306. doi 10.151713543784.2015.1076390. Epub 2015 Aug 14. PubMed PMID 26292923.